MTA3D Trademark

Trademark Overview

On Monday, July 11, 2022, a trademark application was filed for MTA3D with the United States Patent and Trademark Office. The USPTO has given the MTA3D trademark a serial number of 97496958. The federal status of this trademark filing is REGISTERED as of Tuesday, April 8, 2025. This trademark is owned by Treace Medical Concepts, Inc.. The MTA3D trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical trials, namely, providing medical and scientific research information in the field of clinical trials
mta3d

General Information

Serial Number97496958
Word MarkMTA3D
Filing DateMonday, July 11, 2022
Status700 - REGISTERED
Status DateTuesday, April 8, 2025
Registration Number7755104
Registration DateTuesday, April 8, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2023

Trademark Statements

Pseudo MarkMTA THREE D
Goods and ServicesClinical trials, namely, providing medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 28, 2022
Primary Code042
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateSaturday, December 31, 2022

Trademark Owner History

Party NameTreace Medical Concepts, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPonte Vedra, FL 32081
Party NameTreace Medical Concepts, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPonte Vedra, FL 32081
Party NameTreace Medical Concepts, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPonte Vedra, FL 32081

Trademark Events

Event DateEvent Description
Thursday, July 14, 2022NEW APPLICATION ENTERED
Thursday, July 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 5, 2023ASSIGNED TO EXAMINER
Tuesday, January 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 18, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, October 18, 2023USE AMENDMENT FILED
Tuesday, October 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 31, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 29, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, November 29, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 26, 2024ASSIGNED TO LIE
Monday, March 17, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 17, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 8, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, April 8, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, September 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, February 28, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords

clinical trials information field research medical namely providing scientific